The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer

Author(s):
Pelt, G.W. van (0000-0003-1449-7348); Krol, J.A.; Lips, I.M.; Peters, F.P. (0000-0001-9085-447X); Klaveren, D. van; Boonstra, J.J.; Steur, W.O. de; Tollenaar, R.A.E.M. (0000-0002-6831-6082); Sarasqueta, A.F.; Mesker, W.E. (0000-0001-5533-4778); Slingerland, M. (0000-0002-4181-8656)
Published
2020
Publication type
Article / Letter to editor
Esophageal cancerNeoadjuvant chemoradiotherapyPathologic responsePredictionTumor-stroma ratio
Date issued
2020-01-31
Language
English
Publisher
Elsevier
Is part of
Clinical and Translational Radiation Oncology (2020), Vol. 20, p. 39-44
hdl
1887/3181438
doi
10.1016/j.ctro.2019.11.003
URL
https://www.sciencedirect.com/science/article/pii/S2405630819301107?via%3Dihub